Page last updated: 2024-08-23

idarubicin and Sensitivity and Specificity

idarubicin has been researched along with Sensitivity and Specificity in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (42.86)	18.2507
2000's	2 (28.57)	29.6817
2010's	1 (14.29)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Bączek, T; Bień, E; Kowalski, P; Krawczyk, MA; Maliszewska, O; Miękus, N; Olędzka, I; Plenis, A; Rodzaj, W; Treder, N	1
Chignola, R; Dalla Pellegrina, C; Tomelleri, C	1
Balanzategui, A; Chillón, MC; Fernández, C; García Sanz, R; González, MG; Martín-Jiménez, P; San Miguel, JF; Santamaría, C	1
Barbara, C; Bocci, G; Danesi, R; Del Tacca, M; Di Paolo, A; Fogli, S; Innocenti, F	1
Hofmann, S; Kuhlmann, O; Weiss, M	1
Boezeman, J; de Witte, TM; Minderman, H; Pennings, AH; Raymakers, RA; Smeets, ME; Vierwinden, G	1

Trials

1 trial(s) available for idarubicin and Sensitivity and Specificity

Article	Year
An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma. Therapeutic drug monitoring, 1999, Volume: 21, Issue:3 Topics: Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Daunorubicin; Doxorubicin; Drug Monitoring; Epirubicin; Humans; Idarubicin; Linear Models; Molecular Structure; Reference Values; Reproducibility of Results; Sensitivity and Specificity	1999

Article

Year

An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma.

Therapeutic drug monitoring, 1999, Volume: 21, Issue:3

Topics: Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Daunorubicin; Doxorubicin; Drug Monitoring; Epirubicin; Humans; Idarubicin; Linear Models; Molecular Structure; Reference Values; Reproducibility of Results; Sensitivity and Specificity

1999

Other Studies

6 other study(ies) available for idarubicin and Sensitivity and Specificity

Article	Year
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Sensitive Analysis of Idarubicin in Human Urine and Plasma by Liquid Chromatography with Fluorescence Detection: An Application in Drug Monitoring. Molecules (Basel, Switzerland), 2020, Dec-09, Volume: 25, Issue:24 Topics: Antibiotics, Antineoplastic; Chromatography, Liquid; Daunorubicin; Drug Monitoring; Fluorescence; Humans; Idarubicin; Limit of Detection; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction	2020
Microplate spectrophotometry for high-throughput screening of cytotoxic molecules. Cell proliferation, 2010, Volume: 43, Issue:2 Topics: Animals; B-Lymphocytes; Cell Adhesion; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Colchicine; Culture Media; Cytotoxins; Epithelial Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Idarubicin; Kinetics; Leukemia, Biphenotypic, Acute; Paclitaxel; Sensitivity and Specificity; Spectrophotometry; T-Lymphocytes; Time Factors	2010
Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia. Haematologica, 2007, Volume: 92, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Clinical Trials as Topic; Computer Systems; Disease-Free Survival; DNA, Complementary; Drug Monitoring; Female; Follow-Up Studies; Gene Dosage; Humans; Idarubicin; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm, Residual; Oncogene Proteins, Fusion; Polymerase Chain Reaction; Predictive Value of Tests; Recurrence; Remission Induction; Risk Assessment; RNA, Messenger; RNA, Neoplasm; Salvage Therapy; Sensitivity and Specificity; Survival Analysis; Tretinoin	2007
Determination of idarubicin and idarubicinol in rat plasma using reversed-phase high-performance liquid chromatography and fluorescence detection. Journal of chromatography. B, Biomedical sciences and applications, 1999, May-28, Volume: 728, Issue:2 Topics: Animals; Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Daunorubicin; Idarubicin; Male; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence	1999
Idarubicin DNA intercalation is reduced by MRP1 and not Pgp. Leukemia, 1999, Volume: 13, Issue:9 Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Pair Mismatch; Benzimidazoles; Daunorubicin; DNA-Binding Proteins; Energy Transfer; Flow Cytometry; Fluorescent Dyes; Humans; Idarubicin; Intercalating Agents; Multidrug Resistance-Associated Proteins; MutS Homolog 3 Protein; Rhodamines; Sensitivity and Specificity; Spectrometry, Fluorescence; Tumor Cells, Cultured	1999